Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2026)
Caribou Biosciences (CRBU) posted Capital Expenditures of $1,000 for Q2 2026, down 99.8% from $418,000 a year earlier and down 98.6% from the prior quarter.
Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Caribou Biosciences was -$28,000; for FY2025, it was $1.36 million, down 72.2% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
- In prior years, Caribou Biosciences' Capital Expenditures was $4.88 million in FY2024 (-58.0%), $11.61 million in FY2023 (+79.9%), $6.45 million in FY2022 (+204.3%) and $2.12 million in FY2021 (+569.1%).
- Quarterly Capital Expenditures has run from a low of -$216,000 in Q4 2025 to a high of $4.75 million in Q3 2023 over five years.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2022, with growth of 441.3%; the weakest was Q2 2026, with a decline of 99.8%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $72,000 (Q1 2026), -$216,000 (Q4 2025) and $115,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Caribou Biosciences | 134.61 Mn | -381.92 Mn | - | 1,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 723,000.00 |
| Dec 31, 2021 | 685,000.00 |
| Sep 30, 2021 | 930,000.00 |
Caribou Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRBU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();